![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/26 | |
A61K 38/28 | |||
A61P 3/10 | |||
A61P 5/50 |
(11) | Number of the document | 2575865 |
(13) | Kind of document | T |
(96) | European patent application number | 11723919.4 |
Date of filing the European patent application | 2011-05-27 | |
(97) | Date of publication of the European application | 2013-04-10 |
(45) | Date of publication and mention of the grant of the patent | 2014-12-17 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/EP2011/058764 |
Date | 2011-05-27 |
(87) | Number | WO 2011/147980 |
Date | 2011-12-01 |
(30) | Number | Date | Country code |
10164368 | 2010-05-28 | EP |
(72) |
BECKER, Reinhard, DE
HAUCK, Gerrit, DE
|
(73) |
Sanofi-Aventis Deutschland GmbH,
Brüningstra e 50, 65929 Frankfurt am Main,
DE
|
(54) | Pharmaceutical Composition Comprising AVE0010 and Insulin Glargine |
Pharmaceutical Composition Comprising AVE0010 and Insulin Glargine |